Management of Urinary Incontinence in Women: Scientific Review

JAMA

Volumn 291, Issue 8, 2004, Pages 986-995

  Holroyd Leduc, Jayna M ^a,c   Straus, Sharon E ^b,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; CALCIUM CHANNEL BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; DOXEPIN; DULOXETINE; MAGNESIUM HYDROXIDE; MIDODRINE; NIMODIPINE; OXYBUTYNIN; SEROTONIN UPTAKE INHIBITOR; TOLTERODINE; TRICYCLIC ANTIDEPRESSANT AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT;

ABDOMINAL PAIN; ACADEMIC ACHIEVEMENT; ADULT; AGE; ALCOHOL CONSUMPTION; ANXIETY; BODY MASS; COCHRANE LIBRARY; COLPOSUSPENSION; COMORBIDITY; CONFUSION; CONSTIPATION; DIARRHEA; DIZZINESS; DRY EYE; DYSPEPSIA; ECG ABNORMALITY; EDEMA; ELECTROSTIMULATION; EMBASE; FEMALE; GASTROINTESTINAL SYMPTOM; GYNECOLOGIC DISEASE; HEADACHE; HEART ARRHYTHMIA; HEART PALPITATION; HUMAN; HYPOTENSION; HYSTERECTOMY; MAJOR CLINICAL STUDY; MEDLINE; MUSCLE CRAMP; MUSCLE TRAINING; MYALGIA; NAUSEA; PARITY; PELVIS FLOOR; PRIORITY JOURNAL; QUALITY OF LIFE; RACE; RASH; REVIEW; RISK BENEFIT ANALYSIS; SEIZURE; SELF REPORT; SMOKING; SOCIAL STATUS; SOMNOLENCE; TACHYCARDIA; URINE INCONTINENCE; URINE RETENTION; VAGINA RECONSTRUCTION; VISUAL DISORDER; VOMITING; XEROSTOMIA; BLADDER; ELECTROSTIMULATION THERAPY; MULTIMODALITY CANCER THERAPY; PHYSIOTHERAPY; RISK FACTOR; VAGINA;

ADRENERGIC ALPHA-AGONISTS; CHOLINERGIC ANTAGONISTS; COMBINED MODALITY THERAPY; ELECTRIC STIMULATION THERAPY; FEMALE; HUMANS; PHYSICAL THERAPY MODALITIES; RISK FACTORS; URINARY BLADDER; URINARY INCONTINENCE; VAGINA;

EID: 1442359546     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.291.8.986     Document Type: Review

References (76)

1. Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology. 2003;61:37-49.
2. Thom D. Variation in estimates of urinary incontinence prevalence in the community: effects of differences in definition, population characteristics, and study type. J Am Geriatr Soc. 1998;46:473-480.
3. Herzog AR, Fultz NH. Prevalence and incidence of urinary incontinence in community-dwelling populations. J Am Geriatr Soc. 1990;38:273-281.
4. Johnson TM II, Kincade JE, Bernard SL, Busby-Whitehead J, Hertz-Picciotto J, DeFriese GH. The association of urinary incontinence with poor self-rated health. J Am Geriatr Soc. 1998;46:693-699.
5. Temml C, Haidinger G, Schmidbauer J, Schatzl G, Madersbacher S. Urinary Incontinence in both sexes: prevalence rates and impact on quality of life and sexual life. Neurourrol Urodyn. 2000;19:259-271.
6. Wyman JF, Harkins SW, Fantl JA. Psychosocial impact of urinary incontinence in the community-dwelling population. J Am Geriatr Soc. 1990;38:282-288.
7. Dugan E, Cohen SJ, Bland DR, et al. The association of depressive symptoms and urinary incontinence among older adults. J Am Geriatr Soc. 2000;48:413-416.
8. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy post-menopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321-333.
9. Viktrup L, Lose G. The risk of stress incontinence 5 years after first delivery. Am J Obstet Gynecol. 2001;185:82-87.
10. Sampselle CM, Harlow SD, Skurnick J, Brubaker L, Bondarenko I. Urinary incontinence predictors and life impact in ethnically diverse perimenopausal women. Obstet Gynecol. 2002;100:1230-1238.
11. Moller LM, Lose G, Jorgensen T. Risk factors for lower urinary tract symptoms in women 40 to 60 years of age. Obstet Gynecol. 2000;96:446-451.
12. Bortolotti A, Bernardini B, Colli E, et al. Prevalence and risk factors for urinary incontinence in Italy. Eur Urol. 2000;37:30-35.
13. Schmidbauer J, Temml C, Schatzl G, Haidinger G, Madersbacher S. Risk factors for urinary incontinence in both sexes: analysis of a health screening project. Eur Urol. 2001;39:565-570.
14. Chiarelli P, Brown W, McElduff P. Leaking urine: prevalence and associated factors in Australian women. Neurourol Urodyn. 1999;18:567-577.
15. Samuelsson E, Victor A, Svardsudd K. Determinants of urinary incontinence in a population of young and middle-aged women. Acta Obstet Gynecol Scand. 2000;79:208-215.
16. Sherburn M, Guthrie JR, Dudley EC, O'Connell HE, Dennerstein L. Is incontinence associated with menopause? Obstet Gynecol. 2001;98:628-633.
17. Rortveit G, Hannestad YS, Daltveit AK, Hunskaar S. Age- and type-dependent effects of parity on urinary incontinence: the Norwegian EPINCONT study. Obstet Gynecol. 2001;98:1004-1010.
18. Persson J, Wolner-Hanssen P, Rydhstroem H. Obstetric risk factors for stress urinary incontinence: a population-based study. Obstet Gynecol. 2000;96:440-445.
19. Rortveit G, Daltveit AK, Hannestad YS, Hunskaar S. Urinary Incontinence after vaginal delivery or cesarean section. N Engl J Med. 2003;348:900-907.
20. Foldspang A, Mommsen S, Djurhuus J. Prevalent urinary incontinence as a correlate of pregancy, vaginal childbirth, and obstetric techniques. Am J Public Health. 1999;99:209-212.
21. Kuh D, Cardozo L, Hardy R. Urinary incontinence in middle aged women: childhood enuresis and other lifetime risk factors in a British prospective cohort. J Epidemiol Community Health. 1999;53:453-458.
22. Arya LA, Jackson ND, Myers DL, Verma A. Risk of new-onset urinary incontinence after forceps and vacuum delivery in primiparous women. Am J Obstet Gynecol. 2001;185:1318-1323; discussion, 1323-1324.
23. Van Kessel K, Reed S, Newton K, Meier A, Lentz G. The second stage of labor and stress urinary incontinence. Am J Obstet Gynecol. 2001;184:1571-1575.
24. Samuelsson EC, Victor FT, Svardsudd KF. Five-year incidence and remission rates of female urinary incontinence in a Swedish population less than 65 years old. Am J Obstet Gynecol. 2000;183:568-574.
25. Challha C, Kalia V, Stanton SL, Monga A, Sultan AH. Antenatal prediction of postpartum urinary and fecal incontinence. Obstet Gynecol. 1999;94(5 pt 1):689-694.
26. Brown JS, Sawaya G, Thom DH, Grady D. Hysterectomy and unnary incontinence: a systematic review. Lancet. 2000;356:535-539.
27. Kjerulff KH, Langenberg PW, Greenaway L, Uman J, Harvey LA. Urinary incontinence and hysterectomy in a large prospective cohort study in American women. J Urol. 2002;167:2088-2092.
28. van der Vaart CH, van der Bom JG, de Leeuw JR, Roovers JP, Heintz AP. The contribution of hysterectomy to the occurrence of urge and stress urinary incontinence symptoms. Bjog. 2002;109:149-154.
29. Roovers JP, van der Bom JG, Huub van der Vaart C, Fousert DM, Heintz AP. Does mode of hysterectomy influence micturition and defecation? Acta Obstet Gynecol Scand. 2001;80:945-951.
30. Van Oyen H, Van Oyen P. Urinary incontinence in Belgium; prevalence, correlates and psychosocial consequences. Acta Clin Belg. 2002;57:207-218.
31. Holtedahl K, Hunskaar S. Prevalence, 1-year incidence and factors associated with urinary incontinence: a population based study of women 50-74 years of age in primary care. Maturitas. 1998;28:205-211.
32. Aggazzotti G, Pesce F, Grassi D, et al. Prevalence of urinary incontinence among institutionalized patients: a cross-sectional epidemiologic study in a midsized city in northern Italy. Urology. 2000;56:245-249.
33. Brown JS, Grady D, Ouslander JG, Herzog AR, Varner RE, Posner SF, for the Heart & Estrogen/Progestin Replacement Study (HERS) Research Group. Prevalence of urinary incontinence and associated risk factors in postmenopausal women. Obstet Gynecol. 1999;94:66-70.
34. Nelson R, Furner S, Jesudason V. Urinary Incontinence in Wisconsin skilled nursing facilities: prevalence and associations in common with fecal incontinence. J Aging Health. 2001;13:539-547.
35. Landl F, Cesari M, Russo A, Onder G, Sgadari A, Bernabei R. Benzodiazepines and the risk of urinary incontinence in frail older persons living in the community. Clin Pharmacol Ther. 2002;72:729-734.
36. Finkelstein MM. Medical conditions, medications, and urinary incontinence: analysis of a population-based survey. Can Fam Physician. 2002;48:96-101.
37. Fultz NH, Herzog AR, Raghunathan TE, Wallace RS, Diokno AC. Prevalence and severity of urinary incontinence in older African American and Caucasian women. J Gerontol A Biol Sci Med Sci. 1999;54:M299-M303.
38. Arya LA, Myers DL, Jackson ND. Dietary caffeine intake and the risk for detrusor instability: a case-control study. Obstet Gynecol. 2000;96:85-89.
39. Maggi S, Minicuci N, Langlois J, Pavan M, Enzi G, Crepaldi G. Prevalence rate of urinary incontinence in community-dwelling elderly individuals: the Veneto study. J Gerontol A Biol Sci Med Sci. 2001;56:M14-M15.
40. 12 deficiency and incontinence in older people. Can J Urol. 2000;7:1077-1080.
41. Bo K, Borgen JS. Prevalence of stress and urge urinary incontinence in elite athletes and controls. Med Sci Sports Exerc. 2001;33:1797-1802.
42. Hay-Smith EJ, Bo K, Berghmans LC, et al. Pelvic floor muscle training for urinary incontinence in women [Cochrane Review]. In: Cochrane Library, Issue 1. Chichester, England: John Wiley & Sons; 2003.
43. Hrobjartsson A, Gotzsche PC. Placebo treatment vs no treatment [Cochrane Review]. In: Cochrane Library, Issue 1. Chichester, England: John Wiley & Sons; 2003.
44. Goode PS, Burgio KL, Locher AL, et al. Effect of behavioral training with or without pelvic floor electrical stimulation on stress incontinence in women: a randomized controlled trial. JAMA. 2003;290:345-352.
45. Herbison P, Plevnik S, Mantle J. Weighted vaginal cones for urinary incontinence [Cochrane Review]. In: Cochrane Library. Issue 1. Chichester, England: John Wiley & Sons; 2003.
46. Aukee P, Immonen P, Penttinen J, Laippala P, Airaksinen O. Increase in pelvic floor muscle activity after 12 weeks' training: a randomized prospective pilot study. Urology. 2002;60:1020-1023; discussion, 1023-1024.
47. Morkved S, Bo K, Fjortoft T. Effect of adding biofeedback to pelvic floor muscle training to treat urodynamic stress incontinence. Obstet Gynecol. 2002;100:730-739.
48. Burgio KL, Goode PS, Locher JL, et al. Behavioral training with and without biofeedback in the treatment of urge Incontinence in older women: a randomized controlled trial. JAMA. 2002;288:2293-2299.
49. Wyman JF, Fantl JA, McClish DK, Bump RC, for the Continence Program for Women Research Group. Comparative efficacy of behavioral interventions in the management of female urinary incontinence. Am J Obstet Gynecol. 1998;179:999-1007.
50. Janssen CC, Lagro-Janssen AL, Felling AJ. The effects of physiotherapy for female urinary incontinence: individual compared with group treatment. BJU Int. 2001;87:201-206.
51. McDowell BJ, Engberg S, Sereika S, et al. Effectiveness of behavioral therapy to treat incontinence in homebound older adults. J Am Geriatr Soc. 1999;47:309-318.
52. Burgio KL, Locher JL, Goode PS, et al. Behavioral vs drug treatment for urge urinary incontinence in older women: a randomized controlled trial. JAMA. 1998;280:1995-2000.
53. Alhasso A, Glazener CM, Pickard R, N'Dow J. Adrenergic drugs for urinary incontinence in adults (Cochrane Review]. In: Cochrane Library, Issue 1. Chichester, England: John Wiley & Sons; 2003.
54. Yamanishi T, Yasuda K, Sakakibara R, Hattori T, Suda S. Randomized, double-blind study of electrical stimulation for urinary incontinence due to detrusor overactivity. Urology. 2000;55:353-357.
55. Jeyaseelan SM, Haslam EJ, Winstanley J, Roe BH, Oldham JA. An evaluation of a new pattern of electrical stimulation as a treatment for urinary stress incontinence: a randomized, double-blind, controlled trial. Clin Rehabil. 2000;14:631-640.
56. Roe B, Williams K, Palmer M. Bladder training for urinary incontinence in adults [Cochrane Review]. In: Cochrane Library, Issue 1. Chichester, England: John Wiley & Sons; 2003.
57. Eustice S, Roe B, Paterson J. Prompted voiding for the management of urinary incontinence in adults [Cochrane Review]. In: Cochrane Library, Issue 1. Chichester, England: John Wiley & Sons; 2003.
58. Hay-Smith J, Herbison P, Ellis G, Moore K. Anticholinergic drugs versus placebo for overactive bladder syndrome in adults [Cochrane Review]. In: Cochrane Library, Issue 1. Chichester, England: John Wiley & Sons; 2003.
59. Zinner NR, Mattiasson A, Stanton SL. Efficacy, safety, and tolerability of extended-release once-daily tolterodine treatment for overactive bladder in older vs younger patients. J Am Geriatr Soc. 2002;50:799-807.
60. Leung HY, Yip SK, Cheon C, et al. A randomized controlled trial of tolterodine and oxybutynin on tolerability and clinical efficacy for treating Chinese women with an overactive bladder. BJU Int. 2002;90:375-380.
61. Lee JG, Hong JY, Choo MS, et al. Tolterodine: as effective but better tolerated than oxybutynin in Asian patents with symptoms of overactive bladder. Int J Urol. 2002;9:247-252.
62. Malone-Lee J, Shaffu B, Anand C, Powell C. Tolterodine: superior tolerability than and comparable efficacy to oxybutynin in individuals 50 years old or older with overactive bladder: a randomized controlled trial. J Urol. 2001;165:1452-1456.
63. Appell RA, Sand P, Dmochowski R, et al. Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder: results of the OBJECT Study. Mayo Clin Proc. 2001;76:358-363.
64. Davila GW, Daugherty CA, Sanders SW. A short-term, multicenter, randomized double-blind dose titration study of the efficacy and anticholinergic side effects of transdermal compared to immediate release oral oxybutynin treatment of patients with urge urinary incontinence. J Urol. 2001;166:140-145.
65. Phenylpropanolamine information page. US Food and Drug Administration Web site. Available at: www.fda.gov/cder/drug/infopage/ppa/default.htm. Accessed January 27, 2004 Accessibility verified January 27, 2004/
66. Haeusler G, Leitich H, van Trotsenburg M, Kaider A, Tempfer CB. Drug therapy of urinary urge incontinence: a systematic review. Obstet Gynecol. 2002;100(5 pt 1):1003-1016.
67. Naglie G, Radomski SB, Brymer C, Mathiasen K, O'Rourke K, Tomlinson G. A randomized, double-blind, placebo controlled crossover trial of nimodipine in older persons with detrusor instability and urge incontinence. J Urol. 2002;167(2 pt 1):586-590.
68. Gordon D, Groutz A, Ascher-Landsberg J, Lessing JB, David MP, Razz O. Double-blind, placebo-controlled study of magnesium hydroxide for treatment of sensory urgency and detrusor instability: preliminary results. Br J Obstet Gynaecol. 1998;105:667-669.
69. Norton PA, Zinner NR, Yalcin I, Bump RC. Duloxetine placebo in the treatment of stress urinary incontinence. Am J Obstet Gynecol. 2002;187:40-48.
70. Lapitan MC, Cody DJ, Grant AM. Open retropubic colposuspension for urinary incontinence in women [Cochrane Review]. In: Cochrane Library, Issue 1. Chichester, England: John Wiley & Sons; 2003.
71. Glazener CM, Cooper K. Bladder neck needle suspension for urinary incontinence in women [Cochrane Review]. In: Cochrane Library, Issue 1. Chichester, England: John Wiley & Sons; 2003.
72. Glazener CM, Cooper K. Anterior vaginal repair for urinary incontinence in women [Cochrane Review]. In: Cochrane Library, Issue 1. Chichester, England: John Wiley & Sons; 2003.
73. Moehrer B, Ellis G, Carey M, Wilson PD. Laparoscopic colposuspension for urinary incontinence in women [Cochrane Review]. In: Cochrane Library, Issue 1. Chichester, England: John Wiley & Sons; 2003.
74. Bezerra CA, Bruschini H. Suburethral sling operations for urinary incontinence in women [Cochrane Review]. In: Cochrane Library, Issue 1. Chichester, England: John Wiley & Sons; 2003.
75. Pickard R, Reaper J, Wyness L, Cody DJ, McClinton S, N'Dow J. Periurethral injection therapy for urinary incontinence in women [Cochrane Review]. In: Cochrane Library, Issue 1. Chichester, England: John Wiley & Sons; 2003.
76. Lee PE, Kung RC, Drutz HP. Periurethral autologous fat injection as treatment for female stress urinary incontinence: a randomized double-blind controlled trial. J Urol. 2001;165:153-158.